Access cutting-edge urinary tract infection treatment through this clinical trial at a research site in Fresno. Study-provided care at no cost to qualified participants.
Access urinary tract infection specialists in Fresno at no cost
This study follows strict safety protocols and ethical guidelines
All study-related urinary tract infection treatment provided free
This is a Phase 2 superiority study of LBP-EC01, a recombinant bacteriophage cocktail, with an initial open-label 3-arm pharmacokinetic (PK) lead-in portion of 30 patients to evaluate the optimal dosing regimen to be used in the subsequent 288 patient blinded portion of the study which will be randomized 1:1 comparing LBP-EC01 + antibiotic versus placebo + antibiotic in patients with a history of prior urinary tract infection (UTI) cased by E. coli. All patients will be required to have an activ
Sponsor: Locus Biosciences
Check if you qualify for this urinary tract infection clinical trial in Fresno, CA
If you're searching for urinary tract infection treatment options in Fresno, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fresno research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urinary tract infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.